Yoshihiro Nishikawa

机构：Kyoto University · ORCID：0000-0002-1113-6937

发表论文 245 篇 · 总被引 2277 次 · h-index 25

代表论文

• An overview of the reclassification of COVID-19 of the Infectious Diseases Control Law in Japan (2023 · Global Health & Medicine · 被引 29)
• Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis (2023 · Journal of Gastroenterology · 被引 23)
• Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis (2024 · British Journal of Cancer · 被引 16)
• ELF3 suppresses gallbladder cancer development through downregulation of the EREG / EGFR / mTOR complex 1 signalling pathway (2023 · The Journal of Pathology · 被引 15)
• Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study (2024 · Journal of Gastroenterology · 被引 12)
• Anti-integrin αvβ6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis (2024 · Inflammatory Bowel Diseases · 被引 4)